Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-24
DOI
10.3389/fimmu.2019.02308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues
- (2019) Tetsuya Hosaka et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis B Surface Antigen Loss: Too Little, Too Late and the Challenge for the Future
- (2019) Geoffrey Dusheiko et al. GASTROENTEROLOGY
- Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA
- (2019) En-Qiang Chen et al. JOURNAL OF VIRAL HEPATITIS
- New Biomarkers of Chronic Hepatitis B
- (2019) Lung-Yi Mak et al. Gut and Liver
- A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
- (2019) Tian-Ying Zhang et al. GUT
- Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy
- (2019) Sourina Pal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous HB eAg Seroconversion in HB eAg‐Positive Children with a Normal ALT Level
- (2019) Ho‐Sheng Chen et al. HEPATOLOGY
- Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study
- (2019) Di Wu et al. Hepatology International
- Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B
- (2019) Nina Le Bert et al. JOURNAL OF HEPATOLOGY
- A global scientific strategy to cure hepatitis B
- (2019) Peter A Revill et al. Lancet Gastroenterology & Hepatology
- Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma
- (2019) Wai‐Pan To et al. JOURNAL OF VIRAL HEPATITIS
- Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
- (2018) K. Qiu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
- (2018) Franziska Rinker et al. JOURNAL OF HEPATOLOGY
- Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
- (2018) Alice M. Turner et al. JOURNAL OF HEPATOLOGY
- Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss
- (2018) Christine L Zimmer et al. JOURNAL OF INFECTIOUS DISEASES
- Mechanisms of Hepatitis B Virus Persistence
- (2018) Kuen-Nan Tsai et al. TRENDS IN MICROBIOLOGY
- Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination
- (2018) Claudia Dembek et al. Current Opinion in Virology
- Viral envelope-specific antibodies in chronic hepatitis B virus infection
- (2018) Davide Corti et al. Current Opinion in Virology
- Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
- (2018) Shaohang Cai et al. Infection and Drug Resistance
- Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study
- (2018) Ming-Wei Lai et al. Hepatology International
- PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
- (2018) Loghman Salimzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating and intrahepatic antiviral B cells are defective in hepatitis B
- (2018) Alice R. Burton et al. JOURNAL OF CLINICAL INVESTIGATION
- Entering the spotlight: hepatitis B surface antigen–specific B cells
- (2018) Christoph Neumann-Haefelin et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
- (2018) Mamun Al Mahtab et al. PLoS One
- HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
- (2018) Bhawna Poonia et al. Scientific Reports
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
- (2018) Yee Hui Yeo et al. GASTROENTEROLOGY
- Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
- (2018) Barbara Testoni et al. JOURNAL OF HEPATOLOGY
- Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure
- (2018) Zhaochun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
- (2017) Rohit Loomba et al. GASTROENTEROLOGY
- Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis
- (2017) Sonali Paul et al. HEPATOLOGY
- A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha
- (2017) Zhenhuan Cao et al. HEPATOLOGY
- Hepatitis B cure: From discovery to regulatory approval
- (2017) Anna S. Lok et al. HEPATOLOGY
- Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models
- (2017) Anna D. Kosinska et al. HEPATOLOGY
- The role of quantitative hepatitis B surface antigen revisited
- (2017) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study
- (2017) E. S. Cannizzo et al. JOURNAL OF VIRAL HEPATITIS
- Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
- (2017) Paola Fisicaro et al. NATURE MEDICINE
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
- (2017) Christine I. Wooddell et al. Science Translational Medicine
- Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
- (2017) Jiyuan Zhou et al. Scientific Reports
- Antibody-mediated immunotherapy against chronic hepatitis B virus infection
- (2017) Ying Gao et al. Human Vaccines & Immunotherapeutics
- A potent human neutralizing antibody Fc-dependently reduces established HBV infections
- (2017) Dan Li et al. eLife
- Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen
- (2017) Diana P. Castiblanco et al. Frontiers in Immunology
- TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells
- (2017) Amy N. Suthers et al. Frontiers in Immunology
- Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs
- (2017) Jing Huang et al. Scientific Reports
- Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
- (2016) Andrew Vaillant ANTIVIRAL RESEARCH
- Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection
- (2016) Masataka Tsuge et al. JOURNAL OF GASTROENTEROLOGY
- Adaptive immunity in HBV infection
- (2016) Antonio Bertoletti et al. JOURNAL OF HEPATOLOGY
- Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir
- (2016) J.-H. Xu et al. JOURNAL OF VIRAL HEPATITIS
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- (2016) Mamun Al-Mahtab et al. PLoS One
- Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
- (2015) Robert G. Gish et al. ANTIVIRAL RESEARCH
- Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients
- (2015) Xiangsheng Xu et al. Cellular & Molecular Immunology
- Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen
- (2015) Tian-Ying Zhang et al. GUT
- Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
- (2015) Rong Fan et al. GUT
- Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells
- (2015) Thomas Vanwolleghem et al. HEPATOLOGY
- Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection
- (2015) Zhong Fang et al. JOURNAL OF IMMUNOLOGY
- Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir
- (2015) Femke Stelma et al. JOURNAL OF INFECTIOUS DISEASES
- The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection
- (2015) Yun Bin Lee et al. JOURNAL OF MEDICAL VIROLOGY
- A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect
- (2015) Wei Wang et al. mAbs
- Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease
- (2015) Quan Yuan et al. PLoS One
- Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses
- (2014) Zhiyong Ma et al. Cellular & Molecular Immunology
- Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
- (2014) Wai-Kay Seto et al. JOURNAL OF CLINICAL ONCOLOGY
- Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
- (2014) Qin Ning et al. JOURNAL OF HEPATOLOGY
- Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
- (2014) Bertram Bengsch et al. JOURNAL OF HEPATOLOGY
- Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
- (2014) M. Jiang et al. JOURNAL OF VIRAL HEPATITIS
- Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir
- (2013) R Bart Takkenberg et al. ANTIVIRAL THERAPY
- Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B
- (2013) Mamun Al-Mahtab et al. Hepatology International
- Mobilizing monocytes to cross-present circulating viral antigen in chronic infection
- (2013) Adam J. Gehring et al. JOURNAL OF CLINICAL INVESTIGATION
- Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
- (2013) Dao-Zhen Xu et al. JOURNAL OF HEPATOLOGY
- Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment
- (2013) Wai-Kay Seto et al. JOURNAL OF HEPATOLOGY
- T-cell responses in hepatitis B and C virus infection: similarities and differences
- (2013) Julia Schmidt et al. Emerging Microbes & Infections
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
- (2012) Carolina Boni et al. GASTROENTEROLOGY
- Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
- (2012) Tai-Chung Tseng et al. JOURNAL OF GASTROENTEROLOGY
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
- (2012) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
- (2012) Scott A. Halperin et al. VACCINE
- Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy
- (2011) Curtis Cooper et al. Expert Review of Vaccines
- Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
- (2011) Baidong Hou et al. IMMUNITY
- Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
- (2011) Henry Lik-Yuen Chan et al. JOURNAL OF HEPATOLOGY
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
- (2010) Shigeru Kusumoto et al. JOURNAL OF GASTROENTEROLOGY
- Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections
- (2010) Barbara Oliviero et al. JOURNAL OF HEPATOLOGY
- Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner
- (2010) J. Bessa et al. JOURNAL OF IMMUNOLOGY
- Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance
- (2010) Z.-H. Zhang et al. JOURNAL OF VIRAL HEPATITIS
- B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure
- (2010) P. Farci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination
- (2010) J.C. Valats et al. VACCINE
- Randomized Controlled Study Investigating Viral Suppression and Serological Response following Pre-S1/Pre-S2/S Vaccine Therapy Combined with Lamivudine Treatment in HBeAg-Positive Patients with Chronic Hepatitis B
- (2009) P. T. L. Hoa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
- (2009) Paola Fisicaro et al. GASTROENTEROLOGY
- CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 Years
- (2008) C. L. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells
- (2008) Jun Wu et al. HEPATOLOGY
- Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus
- (2008) Marjoleine L. Op den Brouw et al. IMMUNOLOGY
- Direct Ex Vivo Evaluation of Long‐Lived Protective Antiviral Memory B Cell Responses against Hepatitis B Virus
- (2008) Scott M. Ward et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients
- (2008) Dao-Zhen Xu et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started